Bladder cancer combo trial halted after only 4 patients
Disease control
Terminated
This study tested a combination of two drugs, selinexor and pembrolizumab, in people with advanced bladder cancer who could not take or had stopped responding to the chemotherapy drug cisplatin. The goal was to find the best dose and see if the combination could shrink tumors. Ho…
Phase: PHASE1, PHASE2 • Sponsor: Mamta Parikh • Aim: Disease control
Last updated May 01, 2026 16:00 UTC